CME reviews advances in the aesthetic clinical applications of botulinum neurotoxins. Outlines the similarities and differences between the 2 botulinum neurotoxin products that have been approved for aesthetic use by the US Food and Drug Administration and evaluates patients and develop plans for treatment of the aging face that incorporate botulinum neurotoxins